Clinical Trial Update: DAR-901 TB Booster Vaccine to Prevent TB in Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial results for DAR-901 TB booster vaccine in adolescents completed; study posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• DAR-901

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-11